Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment
Double-blinded, Randomized, Adaptive Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices (Attune™ and Cerena™) as Interventions for Physical and Emotional Health in Adjunctive Oncology Treatment
Sponsor: Blue Note Therapeutics
Terminated
This study was halted prematurely due to slow enrollment
Other terminated trials from Blue Note Therapeutics
- Anatomic Stage I Breast Cancer AJCC v8 · Phase NA · Mar 2023
- AML · Phase NA · Feb 2023
- Cancer · Phase NA · Aug 2022
More terminations from Blue Note Therapeutics
Other Anatomic Stage I Breast Cancer AJCC v8 trials with similar outcome
Listed as NCT04862195, this NA trial focuses on Anatomic Stage I Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8 and remains terminated or withdrawn. Sponsored by Blue Note Therapeutics, it has been updated 11 times since 2021, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2022 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
May 2022 — Sep 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2022 — May 2022 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2022 — Mar 2022 [monthly]
Recruiting NA
-
Nov 2021 — Jan 2022 [monthly]
Recruiting NA
-
Oct 2021 — Nov 2021 [monthly]
Recruiting NA
-
Sep 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Blue Note Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .